Avia Pharma

Avia Pharma at a glance

Avia was founded in 2016 and focuses on medically positioned products within dermatology, allergy, women’s health, urology, and general OTC products. The Company has successfully executed on its strategy to build its own brand portfolio and to grow its Northern European presence over time, through a combination of M&A (having already done 6 since inception), in-licensing of additional products and growing market share across the portfolio. Avia is today a well-diversified platform present across the Nordics and Germany with headquarters in Stockholm, Sweden, and with offices in Germany and Finland.

Avia facts

Sector

Pharmaceuticals

Impilo entry date

December 2023

HQ

Stockholm, Sweden

Management team

Jacob Calmvik (CEO)
Jonas Karlander (CFO)

Impilo team

Carolina Oscarius-Dahl
Gustav J. Lundgren
Olga Court-Payen

No of employees

90

Revenue development, SEKm

2021
2022
2023

EBITDA development, SEKm

2021
2022
2023

Investment Thesis

  • Exposure to large and fundamentally attractive OTC and Rx market niches
  • Existing portfolio comprising high-quality products
  • Organic and semi-organic profitable growth initiatives across existing and new products
  • Platform for M&A growth across Northern European countries

UN SDG Goals